Interview Released with Robert Vries, CEO at Hubrecht Organoid Technology speaker at 3D Cell Culture

SMi Reports: Speaker interview released for SMi's 5th Annual 3D Cell Culture taking place on 10 – 11 February 2021 as a virtual conference with online access only.
By: SMi Group
P 340 1200x627 Robert Vries Virtual
P 340 1200x627 Robert Vries Virtual
LONDON - Nov. 30, 2020 - PRLog -- With SMi Group's 3D Cell Culture returning for its 5th year on the 10th and 11th February 2021, as a virtual conference with online access only, the two-day conference is anticipated to have a closer look at various topics regarding developing complex physiologically relevant cell models in vitro.

SMi Group had the opportunity to speak with our key speaker Robert Vries, CEO at Hubrecht Organoid Technology for the conference.

Robert Vries received his PhD in Biochemistry from the Leiden University Medical Center on a molecular study of oncogenic transformation. He subsequently moved to Stanford University (USA) to do his Post Doc studying neural stem cells. In the group of Hans Clevers, he was part of the team that developed the breakthrough technology that allowed the expansion of adult stem cells. The so-called Organoid Technology became the basis of the non-profit company 'Hubrecht Organoid Technology' (HUB) of which he is currently the CEO.

Robert Vries in depth speaker interview can be downloaded on the conference website in the 'download centre', and below is a snippet of the exclusive interview.

What is the greatest challenge for you to personally overcome within the 3D Cell Culture field currently?
'The key obstacles have been two-fold. Firstly, there are the technical challenges: organoid technology is an advanced cell line technology, and it brings with it the issues of being less readily reproducible in the lab. Fundamentally, if the technical conditions cannot be aligned there will be a lower success rate'.

How would you like to see the 3D Cell Culture market develop in the future and where do you think the biggest growth area will be in the next few years?
'In the last 10 years the 3D Cell Culture market has seen consistent growth, and I foresee that this trend will continue. The most significant growth will be in the application of organoid technology to clinical trials, and it is here in which they have the potential to do something new.

Registration is FREE for all active Pharmaceutical Professionals and vendors/Commercial Firms only £499, visit

For sponsorship enquiries contact Alia Malick on +44 (0)20 7827 6164 or

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6162 or

3D Cell Culture Conference 2021
10th - 11th February 2021
Virtual Conference: Online Access Only

SMi Group
Simi Sapal
Email:*** Email Verified
Tags:3D cell culture
Location:London City - London, Greater - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
SMi Group Ltd. News
Most Viewed
Daily News

Most Viewed
Daily News
PTC News

Nov 30, 2020 News

Like PRLog?
Click to Share